TrialResults-center.org
Search
Menu
Home
Search
Recent trials
Browse pathology
Browse treatment
About us
Brigatinib
ALK inhibitors
Description
NMA
NMA
brigatinib - AP26113
Group by
Group by...
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in first
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in second
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
clinical condition
in third
lung cancer (metastatic)
death (overall survival)
progression or death (progression free survival PFS)
pdf
pathology
k
Demonstrated benefit and harm
×
Modal title